A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2

被引:0
作者
Xiaocong Wu
Hui Chen
Chao You
Zongjun Peng
机构
[1] Sichuan Friendship Hospital,Department of Neurosurgery
[2] Sichuan University,Department of Neurosurgery, West China Hospital
来源
Hereditas | / 160卷
关键词
SHOX2; Pan-cancer; Prognosis; Immune; Glioma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 205 条
[1]  
Puskaric S(2010)Shox2 mediates Tbx5 activity by regulating Bmp4 in the pacemaker region of the developing heart Hum Mol Genet 19 4625-33
[2]  
Schmitteckert S(2009)Shox2 is essential for the differentiation of cardiac pacemaker cells by repressing Nkx2-5 Dev Biol 327 376-85
[3]  
Mori AD(2008)DNA methylation in development and human disease Mutat Res 647 30-8
[4]  
Glaser A(2016)Epigenetics and human disease Cold Spring Harb Perspect Biol 8 a19497-67
[5]  
Schneider KU(2022)DNA N(6)-methyldeoxyadenosine in mammals and human disease Trends Genet 38 454-S649
[6]  
Bruneau BG(2013)Elevated SHOX2 expression is associated with tumor recurrence of hepatocellular carcinoma Ann Surg Oncol 20 644-75
[7]  
Blaschke RJ(2014)Helicobacter pylori-induced STAT3 activation and signalling network in gastric cancer Oncoscience 1 468-60
[8]  
Steinbeisser H(2021)SHOX2 cooperates with STAT3 to promote breast cancer metastasis through the transcriptional activation of WASF3 J Exp Clin Cancer Res 40 274-14
[9]  
Rappold G(2021)YTHDF1 is a potential pan-cancer biomarker for prognosis and immunotherapy Front Oncol 11 607224-63
[10]  
Espinoza-Lewis RA(2019)GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis Nucleic Acids Res 47 W556-8